In-Vitro Diagnostics Global Market Report 2021: COVID-19 Implications and Growth to 2030

In-Vitro Diagnostics Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for in-vitro diagnostics which play a critical role to detect the COVID-19 virus.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the in-vitro diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-Vitro Diagnostics Market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider in-vitro diagnostics market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
The in-vitro diagnostics market section of the report gives context. It compares the in-vitro diagnostics market with other segments of the in-vitro diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, in-vitro diagnostics indicators comparison.

Scope

Markets Covered:
1) By Type: Point-of-Care Diagnostics Devices and Equipment; Immunochemistry Diagnostic Devices and Equipment; Clinical Chemistry Diagnostics Devices and Equipment; Molecular Diagnostics Devices and Equipment; Microbiology Diagnostic Devices and Equipment; Hemostasis Diagnostic Devices and Equipment; Hematology Diagnostic Devices and Equipment; Immunohematology Diagnostic Devices and Equipment
2) By End User: Hospitals and Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables

Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc; Thermo Fisher Scientific Inc

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, in-vitro diagnostics indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Frequently Asked Questions about the Global In-Vitro Diagnostics Market

What is the estimated value of the Global In-Vitro Diagnostics Market?

The Global In-Vitro Diagnostics Market was estimated to be valued at $80.12 billion in 2021.

What is the growth rate of the Global In-Vitro Diagnostics Market?

The growth rate of the Global In-Vitro Diagnostics Market is 7.1%, with an estimated value of $105.3 billion by 2025.

What is the forecasted size of the Global In-Vitro Diagnostics Market?

The Global In-Vitro Diagnostics Market is estimated to be worth $105.3 billion by 2025.

Who are the key companies in the Global In-Vitro Diagnostics Market?

Key companies in the Global In-Vitro Diagnostics Market include Siemens Healthineers, F. Hoffmann, La Roche Ltd, Danaher (Beckman Coulter Inc) and Thermo Fisher Scientific Inc.

Report Attribute	Details
Published	February 2021
Forecast Period	2021 - 2025
Estimated Market Value ( USD ) in 2021	$ 80.12 billion
Forecasted Market Value ( USD ) by 2025	$ 105.3 billion
Compound Annual Growth Rate	7.1%
Regions Covered	Global

1. Executive Summary2. Report Structure

3. In-Vitro Diagnostics Market Characteristics

3.1. Market Definition
3.2. Key Segmentations

4. In-Vitro Diagnostics Market Product Analysis

4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. In-Vitro Diagnostics Market Supply Chain

5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. In-Vitro Diagnostics Market Customer Information

6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. In-Vitro Diagnostics Market Trends and Strategies8. Impact of COVID-19 on In-Vitro Diagnostics

9. In-Vitro Diagnostics Market Size and Growth

9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. In-Vitro Diagnostics Market Regional Analysis

10.1. Global In-Vitro Diagnostics Market, 2020, by Region, Value ($ Billion)
10.2. Global In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global In-Vitro Diagnostics Market, Growth and Market Share Comparison, by Region

11. In-Vitro Diagnostics Market Segmentation

11.1. Global In-Vitro Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Point-of-Care Diagnostics Devices and Equipment
Immunochemistry Diagnostic Devices and Equipment
Clinical Chemistry Diagnostics Devices and Equipment
Molecular Diagnostics Devices and Equipment
Microbiology Diagnostic Devices and Equipment
Hemostasis Diagnostic Devices and Equipment
Hematology Diagnostic Devices and Equipment
Immunohematology Diagnostic Devices and Equipment

11.2. Global In-Vitro Diagnostics Market, Segmentation by End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Hospitals and Clinics
Diagnostic Laboratories
Others

11.3. Global In-Vitro Diagnostics Market, Segmentation by Type of Expenditure, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Public
Private

11.4. Global In-Vitro Diagnostics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Instruments/Equipment
Disposables

12. In-Vitro Diagnostics Market Metrics

12.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Global
12.2. Per Capita Average In-Vitro Diagnostics Market Expenditure, 2015-2025, Global

13. Asia-Pacific In-Vitro Diagnostics Market

13.1. Asia-Pacific In-Vitro Diagnostics Market Overview

Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. Asia-Pacific, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
13.3. Asia-Pacific, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
13.4. Asia-Pacific, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
13.5. Asia-Pacific, In-Vitro Diagnostics Market Metrics
13.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Asia-Pacific Countries
13.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, Asia-Pacific Countries
13.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, Asia-Pacific Countries
13.6. Asia-Pacific In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis
13.7.1. China In-Vitro Diagnostics Market
13.7.1.1. China In-Vitro Diagnostics Market Overview
13.7.1.2. China In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.1.3. China In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2. Australia In-Vitro Diagnostics Market
13.7.2.1. Australia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong In-Vitro Diagnostics Market
13.7.3.1. Hong Kong In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4. India In-Vitro Diagnostics Market
13.7.4.1. India In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4.2. India In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia In-Vitro Diagnostics Market
13.7.5.1. Indonesia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6. Japan In-Vitro Diagnostics Market
13.7.6.1. Japan In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia In-Vitro Diagnostics Market
13.7.7.1. Malaysia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand In-Vitro Diagnostics Market
13.7.8.1. New Zealand In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.9. Philippines In-Vitro Diagnostics Market
13.7.9.1. Philippines In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.10. Singapore In-Vitro Diagnostics Market
13.7.10.1. Singapore In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11. South Korea In-Vitro Diagnostics Market
13.7.11.1. South Korea In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.12. Thailand In-Vitro Diagnostics Market
13.7.12.1. Thailand In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam In-Vitro Diagnostics Market
13.7.13.1. Vietnam In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe In-Vitro Diagnostics Market

14.1. Western Europe In-Vitro Diagnostics Market Overview
14.2. Western Europe, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
14.3. Western Europe, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Western Europe, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Western Europe, In-Vitro Diagnostics Market Metrics
14.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Western Europe Countries
14.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, Western Europe Countries
14.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, Western Europe Countries
14.6. Western Europe In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Western Europe In-Vitro Diagnostics Market: Country Analysis
14.7.1. Austria In-Vitro Diagnostics Market
14.7.1.1. Austria In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Belgium In-Vitro Diagnostics Market
14.7.2.1. Belgium In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Denmark In-Vitro Diagnostics Market
14.7.3.1. Denmark In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. Finland In-Vitro Diagnostics Market
14.7.4.1. Finland In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. France In-Vitro Diagnostics Market
14.7.5.1. France In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. France In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Germany In-Vitro Diagnostics Market
14.7.6.1. Germany In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Ireland In-Vitro Diagnostics Market
14.7.7.1. Ireland In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. Italy In-Vitro Diagnostics Market
14.7.8.1. Italy In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands In-Vitro Diagnostics Market
14.7.9.1. Netherlands In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Norway In-Vitro Diagnostics Market
14.7.10.1. Norway In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. Portugal In-Vitro Diagnostics Market
14.7.11.1. Portugal In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Spain In-Vitro Diagnostics Market
14.7.12.1. Spain In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Sweden In-Vitro Diagnostics Market
14.7.13.1. Sweden In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland In-Vitro Diagnostics Market
14.7.14.1. Switzerland In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15. UK In-Vitro Diagnostics Market
14.7.15.1. UK In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15.2. UK In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe In-Vitro Diagnostics Market

15.1. Eastern Europe In-Vitro Diagnostics Market Overview
15.2. Eastern Europe, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
15.3. Eastern Europe, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Eastern Europe, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Eastern Europe, In-Vitro Diagnostics Market Metrics
15.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Eastern Europe Countries
15.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, Eastern Europe Countries
15.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, Eastern Europe Countries
15.6. Eastern Europe In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe In-Vitro Diagnostics Market: Country Analysis
15.7.1. Czech Republic In-Vitro Diagnostics Market,
15.7.1.1. Czech Republic In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Poland In-Vitro Diagnostics Market
15.7.2.1. Poland In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Romania In-Vitro Diagnostics Market
15.7.3.1. Romania In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Russia In-Vitro Diagnostics Market
15.7.4.1. Russia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America In-Vitro Diagnostics Market

16.1. North America In-Vitro Diagnostics Market Overview
16.2. North America, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
16.3. North America, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. North America, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. North America, In-Vitro Diagnostics Market Metrics
16.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, North America Countries
16.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, North America Countries
16.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, North America Countries
16.6. North America In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. North America In-Vitro Diagnostics Market: Country Analysis
16.7.1. Canada In-Vitro Diagnostics Market
16.7.1.1. Canada In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Mexico In-Vitro Diagnostics Market
16.7.2.1. Mexico In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. USA In-Vitro Diagnostics Market
16.7.3.1. USA In-Vitro Diagnostics Market Overview
16.7.3.2. USA In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3.3. USA In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America In-Vitro Diagnostics Market

17.1. South America In-Vitro Diagnostics Market Overview
17.2. South America, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
17.3. South America, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. South America, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. South America, In-Vitro Diagnostics Market Metrics
17.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, South America Countries
17.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, South America Countries
17.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, South America Countries
17.6. South America In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. South America In-Vitro Diagnostics Market: Country Analysis
17.7.1. Argentina In-Vitro Diagnostics Market
17.7.1.1. Argentina In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Brazil In-Vitro Diagnostics Market
17.7.1.1. Brazil In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. Chile In-Vitro Diagnostics Market
17.7.3.1. Chile In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.4. Colombia In-Vitro Diagnostics Market
17.7.4.1. Colombia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.5. Peru In-Vitro Diagnostics Market
17.7.5.1. Peru In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela In-Vitro Diagnostics Market
17.7.6.1. Venezuela In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East In-Vitro Diagnostics Market

18.1. Middle East In-Vitro Diagnostics Market Overview
18.2. Middle East, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
18.3. Middle East, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. Middle East, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. Middle East, In-Vitro Diagnostics Market Metrics
18.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Middle East Countries
18.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, Middle East Countries
18.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, Middle East Countries
18.6. Middle East In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. Middle East In-Vitro Diagnostics Market: Country Analysis
18.7.1. Saudi Arabia In-Vitro Diagnostics Market
18.7.1.1. Saudi Arabia In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Israel In-Vitro Diagnostics Market
18.7.2.1. Israel In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Turkey In-Vitro Diagnostics Market
18.7.3.1. Turkey In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. UAE In-Vitro Diagnostics Market
18.7.4.1. UAE In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa In-Vitro Diagnostics Market

19.1. Africa In-Vitro Diagnostics Market Overview
19.2. Africa, In-Vitro Diagnostics Market, 2020, by Country, Value ($ Billion)
19.3. Africa, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Africa, In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Africa, In-Vitro Diagnostics Market Metrics
19.5.1. In-Vitro Diagnostics Market Size, Percentage of GDP, 2015-2025, Africa Countries
19.5.2. Number of Enterprises, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Enterprises, 2020, Africa Countries
19.5.3. Number of Employees, In-Vitro Diagnostics Market, In-Vitro Diagnostics Market/Number of Employees, 2020, Africa Countries
19.6. Africa In-Vitro Diagnostics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Africa In-Vitro Diagnostics Market: Country Analysis
19.7.1. Egypt In-Vitro Diagnostics Market
19.7.1.1. Egypt In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria In-Vitro Diagnostics Market
19.7.2.1. Nigeria In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. South Africa In-Vitro Diagnostics Market
19.7.3.1. South Africa In-Vitro Diagnostics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. In-Vitro Diagnostics Market Competitive Landscape

20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Siemens Healthineers
20.3.1.1. Company Overview
20.3.1.2. Products and Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. F. Hoffmann-La Roche Ltd
20.3.2.1. Company Overview
20.3.2.2. Products and Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Danaher (Beckman Coulter Inc)
20.3.3.1. Company Overview
20.3.3.2. Products and Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. Abbott Laboratories Inc
20.3.4.1. Company Overview
20.3.4.2. Products and Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Thermo Fisher Scientific Inc
20.3.5.1. Company Overview
20.3.5.2. Products and Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers and Acquisitions in the In-Vitro Diagnostics Market

22. Market Background: Medical Equipment Market

22.1. Medical Equipment Market Characteristics
22.2. Medical Equipment Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global
22.3. Global Medical Equipment Market, 2020, by Region, Value ($ Billion)
22.4. Global Medical Equipment Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
22.5. Global Medical Equipment Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion)

23. Recommendations

23.1. Global In-Vitro Diagnostics Market in 2025 - Growth Countries
23.2. Global In-Vitro Diagnostics Market in 2025 - Growth Segments
23.3. Global In-Vitro Diagnostics Market in 2025 - Growth Strategies

24. Appendix

24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer

Executive Summary

Major companies in the in-vitro diagnostics market include Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc and Thermo Fisher Scientific Inc.

The global in-vitro diagnostics market is expected to grow from $71.71 billion in 2020 to $80.12 billion in 2021 at a compound annual growth rate (CAGR) of 11.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $105.3 billion in 2025 at a CAGR of 7%.

The in-vitro diagnostics devices and equipment market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics equipment. In-vitro diagnostics are tests performed on samples collected from human body such as tissues and blood. The in-vitro diagnostics equipment market is segmented into point-of-care diagnostics devices and equipment; immunochemistry diagnostic devices and equipment; clinical chemistry diagnostics devices and equipment; molecular diagnostics devices and equipment; microbiology diagnostic devices and equipment; hemostasis diagnostic devices and equipment; hematology diagnostic devices and equipment; immunohematology diagnostic devices and equipment.

North America was the largest region in the global in-vitro diagnostics market, accounting for 35% of the market in 2020. Asia Pacific was the second largest region accounting for 31% of the global in-vitro diagnostics market. Africa was the smallest region in the global in-vitro diagnostics market.

IVD devices are being integrated with IoT and data analytics technologies to improve device efficiency and increase device security. IoT refers to a system of interconnected devices via communication technologies such as WIFI and Bluetooth for data transfer and accessing devices remotely. Data analytics refers to qualitative and quantitative techniques, used to infer actionable information from large data sets. These technologies are helping in enhancing IVD device functionality, mainly through remote monitoring, predictive maintenance for decreased downtime and advanced data processing capabilities.

Demand for point-of-care diagnostic devices is increasing as they provide rapid results, are cost effective and have advanced diagnosis features for patients. The number of patients seeking treatments at local physician offices, retail clinics and in-patient homes are increasing thus boosting the demand for point-of-care testing devices. Companies in this market are focusing on developing more user friendly, reliable and efficient point of care devices. For instance, in July 2016, Spartan Bioscience introduced Spartan Cube, the world's smallest DNA-testing system that allows quick DNA testing. Philips also launched a new handheld blood test, Handheld Minicare I-20 system used for diagnosing heart attacks in emergency departments which provide results within 10 minutes.